Bhatt, Deepak L.
Article History
First Online: 3 January 2018
Competing interests
: D.L.B. declares the following relationships. Advisory Board: Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, Regado Biosciences. Board of Directors: Boston VA Research Institute, Society of Cardiovascular Patient Care. Chair: American Heart Association Quality Oversight Committee. Data Monitoring Committees: Cleveland Clinic, Duke Clinical Research Institute, Harvard Clinical Research Institute (PORTICO DSMB), Mayo Clinic, Mount Sinai School of Medicine, Population Health Research Institute. Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org), Belvoir Publications (Editor in Chief, <i>Harvard Heart Letter</i>), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (RE-DUAL executive committee), HMP Communications (Editor in Chief, <i>Journal of Invasive Cardiology</i>), <i>Journal of the American College of Cardiology</i> (Guest Editor; Associate Editor), Population Health Research Institute (COMPASS steering committee, operations committee, publications committee, and US national co-leader), Slack Publications (Chief Medical Editor, <i>Cardiology Today</i>'s Intervention), Society of Cardiovascular Patient Care (Secretary/Treasurer), WebMD (CME steering committees). Other: <i>Clinical Cardiology</i> (Deputy Editor), NCDR-ACTION Registry Steering Committee (Chair), VA CART Research and Publications Committee (Chair). Research Funding: Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi Aventis, The Medicines Company. Royalties: Elsevier (Editor, <i>Cardiovascular Intervention: A Companion to Braunwald's Heart Disease</i>). Site Co-Investigator: Biotronik, Boston Scientific, St. Jude Medical (now Abbott). Trustee: American College of Cardiology. Unfunded Research: FlowCo, Merck, PLx Pharma, Takeda.